Ochre Bio
- Biotech or pharma, therapeutic R&D
Ochre Bio is a biotechnology company developing novel RNA medicines for late-stage chronic liver diseases, including liver fibrosis and cirrhosis.
Its proprietary discovery platform combines machine learning and causal human data, with in-house RNA chemistry, and testing in human liver validation models.
Ochre Bio is headquartered in Oxford, UK, and has research labs in New York and Taipei.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}